Parkinson's disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 ...

Parkinson’s disease is the fastest growing neurological disorder, with over 10 million cases worldwide. Up to 150,000 Australians currently live with the disease and 50 new cases are diagnosed each ...

Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...

Parkinson’s Cafe@AH allows multidisciplinary teams to monitor patients in a relaxed environment. Read more at straitstimes.com. Read more at straitstimes.com.

New research based on nearly 11,000 people shows Parkinson's can present differently in men and women, with distinct symptom patterns and risk exposures that may influence diagnosis and care.

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...

A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...

A doctor has spoken out in a bid to raise awareness of some of the lesser known early symptoms of Parkinson's disease.

ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear ...

“Yes, doctor. My dad’s first fall was on his 65th birthday. He stood in the driveway and suddenly dropped backwards on his back. After he fell two more times, we came to the clinic.” The symptoms the ...

Growing older is the greatest risk factor for getting Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...